by Jill Hostetler | Feb 6, 2019 | Advocacy
The final months of 2018 were a whirlwind beyond the usual frenzied legislative activity of “lame duck” – with Ohio’s legislators staying in session until just days before the Christmas holiday, and returning for more action just days after. This scenario is extremely...
by Jill Hostetler | Feb 6, 2019 | News
The ODA has had an “A-Mazing” year navigating the challenges in dermatology in 2018: In advocacy, the STEP Therapy Bill passed the house and senate. It will be signed into law by the governor. The compounding rules have been challenged and are being revised. In...
by Jill Hostetler | Jan 16, 2019 | Advocacy
After a late push by supporters at the end of the 132nd General Assembly, a proposal to set restrictions on health insurers’ step therapy protocols has reached the end of the legislative process. The measure was folded into separate legislation that would allow...
by Jill Hostetler | Nov 19, 2018 | Advocacy
https://www.dispatch.com/news/20181113/bill-would-streamline-prescription-relief-for-patients The Columbus Dispatch Bill would streamline prescription relief for patients By Catherine Candisky The Columbus Dispatch Nov 13, 2018 Physicians and patient advocates are...
by Jill Hostetler | Nov 19, 2018 | Advocacy
The U.S. Pharmacopeial Convention (USP) is currently revising its standards in its General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. These standards are considered for adoption by incorporation by state pharmacy boards, CMS, CDC, and The...
